Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Benign prostatic hyperplasia
Age: Adult
Dose: Oral – 2.5 mg
Frequency: three times daily
Note: Maximum: 10 mg/day. 1st dose should be given before bedtime.
Indication: Benign prostatic hyperplasia
Age: Adult
Dose: Oral Extended-release – 10 mg
Frequency: once daily

Child Dose

Clinical InformationAdministration Information
Age: Child
Dose: Tablet – No approved pediatric dosage available
Note: Not recommended

Renal Dose

Clinical InformationAdministration Information
Condition: Renal Impairment
Dose: Tablet – 2.5 mg
Frequency: twice daily
Note: Initially, 2.5 mg twice daily. Adjust dose according to response.
Administration
  • Take after same meal each day
  • Swallow whole tablet
Side Effect

Drug Interaction

Drug NameRisk Factors
QT-prolonging Drugs (Various agents that affect cardiac conduction)
Additive effect on QT interval prolongation
Other α1-adrenergic blocking agents, Atenolol, Diltiazem
May result in additive CV effects

Disease Interaction

Disease NameRisk Factors
Severe Hepatic Impairment
Risk of liver complications
Postural Hypotension
Risk of severe dizziness

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool and dry place, protected from light

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.